The Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Spinal cord injury therapeutics are medicinal products aimed at treating various injuries to the spinal cord. These include pharmacological therapies, reconstructive surgeries and rehabilitation therapies. Spinal cord injuries can occur due to trauma, tumors or degenerative disorders. The therapeutics help in the repair and regeneration of damaged nerve tissues, reduce inflammation and manage pain. Their adoption allows for faster recovery and improved quality of life for patients.
Market key trends:
One of the major trends driving growth in this market is the increasing research and development activities for developing advanced therapies. Over the past few years, substantial investments have been made towards developing cell-based and gene-based therapies for spinal cord injuries. Companies are collaborating to conduct clinical trials on stem cell therapies, gene therapies and neural interfaces. For instance, Swiss biotech company SpinalCyte is collaborating with Teva Pharmaceuticals to evaluate a stem cell-based therapy for chronic cervical spinal cord injuries. SpinalCyte’s therapy uses stem cells derived from adipose tissue to reduce inflammation and promote nerve regeneration at the injury site. Such emerging therapies hold promise to significantly improve functional recovery in patients. Their successful development and commercialization will further augment the growth of this market during the forecast period.
Porter’s Analysis
Threat of new entrants: Low costs of production for new entrants given the specialized nature of the market. However, the necessity for strong R&D capabilities and regulations pose a barrier.
Bargaining power of buyers: Buyers have significant bargaining power given the availability of alternative treatment options and ability to negotiate on price. Their bargaining power is expected to increase with rising demand.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to limited availability of raw materials and dependence of buyers on crucial inputs. However, the presence of substitutes keeps their power in check.
Threat of new substitutes: Threat of new substitutes remains high with ongoing innovation and research leading to newer treatment alternatives.
Competitive rivalry: Intense due to numerous established players and large revenue potential.
SWOT Analysis
Strengths: Strong R&D abilities, diversified product portfolio, global presence for major players.
Weaknesses: High costs associated with development and clinical trials, stringent regulations delaying market entry.
Opportunities: Rising incidence rates, growing geriatric population susceptible to conditions, collaborations for new product development.
Threats: Patent cliffs on blockbuster drugs, pricing pressures, uncertainties around reimbursements.
Key Takeaways
The global Spinal Cord Injury Therapeutics Market Trend is expected to witness high growth, exhibiting CAGR of 5.4% over the forecast period, due to increasing incidence of spinal cord injuries from road accidents and trauma cases. North America currently holds the largest share due to high healthcare spending and presence of major market players. However, Asia Pacific is expected to grow at the fastest pace with growth in healthcare infrastructure and raising awareness.
Key players operating in the Spinal Cord Injury Therapeutics market are Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc. The major players are focusing on newer product approvals and strategic collaborations for sustained market leadership.
Read more @ https://www.newsstatix.com/emerging-opportunities-for-cell-therapy-in-spinal-cord-injury-demand/
Spinal cord injury results in dysfunction in the overall body and requires Physiotherapy Treatment.
Learn more about various Spinal injuries.
Read more: https://painfreephysiotherapy.com/how-spinal-cord-injuries-affect-the-body/Spinal Cord Injury
Acute Spinal Cord Injury Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Acute Spinal Cord Injury industry with a focus on the Chinese market.
The report provides key statistics on the market status of the Acute Spinal Cord Injury manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014–2024 global and Chinese Acute Spinal Cord Injury market covering all important parameters.The key ponits of the report:The report provides a basic overview of the industry including its definition, applications and manufacturing technology.The report explores the international and Chinese major industry players in detail.
In this part, the report presents the company profile, product specifications, capacity, production value, and 2014–2019 market shares for each company.Through the statistical analysis, the report depicts the global and Chinese total market of Acute Spinal Cord Injury industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.The report then estimates 2019–2024 market development trends of Acute Spinal Cord Injury industry.
Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.The report makes some important proposals for a new project of Acute Spinal Cord Injury Industry before evaluating its feasibility.Key Questions Addressed by the ReportWhat is the growth perspective of the Acute Spinal Cord Injury Market and the key dynamics and trends governing the market?What are key sustainability strategies adopted by the leading players in the Acute Spinal Cord Injury Market?What are the new and emerging technologies and use cases disrupting the Acute Spinal Cord Injury industry?What are the key applications where Acute Spinal Cord Injury plays a significant role?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-acute-spinal-cord-injury-2019-2024-969There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.For competitor segment, the report includes global key players of Acute Spinal Cord Injury as well as some small players.
At least 7 companies are included:NovartisOxygen BiotherapeuticsBioAxone BioSciencesAOSpine InternationalNeuronaxK-StemcellThe information for each competitor includes:Company ProfileMain Business InformationSWOT AnalysisSales, Revenue, Price and Gross MarginMarket ShareFor product type segment, this report listed main product type of Acute Spinal Cord Injury market in gloabal and china.Laboratory TestsImaging TestsFor end use/application segment, this report focuses on the status and outlook for key applications.
End users sre also listed.HospitalsClinicsReasons to Purchase this Report:Estimates 2019–2024 Acute Spinal Cord Injury market development trends with the recent trends and SWOT analysisMarket dynamics scenario, along with growth opportunities of the market in the years to comeMarket segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspectsRegional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.Market value (USD Million) and volume (Units Million) data for each segment and sub-segmentCompetitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five yearsComprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players1-year analyst support, along with the data support in excel format.Any special requirements about this report, please let us know and we can provide custom report.The report delivers a comprehensive overview of the crucial elements of the market and elements such as drivers, restraints, current trends of the past and present times, supervisory scenario, and technological growth.
